.Location: Barcelona, Spain Job reference: R-208204 Date posted: 09/03/2024 Location: Barcelona, Spain (on - site) 3 days working from the office and 2 days working from homeThe Director, Global Health Economics and Outcomes Research (GHEOR) leads the strategic development and execution of health economics and outcomes research strategies to support the worldwide launch and reimbursement of products across a range of disease areas. This particular role would lead the Real World Evidence and Patient Reported Outcomes as a Center of Excellence to promote capabilities within the Rare Disease portfolio to bring leadership, efficiency and impact to patients with rare disease.Through key leadership and partnership across cross-functional teams, the job holder enables RWE and PRO strategy to be embedded into broader disease area and clinical development strategies via the therapeutic area leaders. This collaboration builds strategies to demonstrate and differentiate the value proposition and corresponding scientific evidence of Alexion products for payers, patients, clinical institutions, and other key influencers. The Director, Global HEOR partners with and provides leadership to HEOR/Medical, Market Access, Clinical Development, and Commercial teams as well as regions and countries. This role reports directly to the Senior Director EUCAN & International Head HEOR. You will be responsible for:Utilizes in-depth knowledge of disease area and portfolio strategy in combination with health economics and outcomes research to develop and build capabilities for RWE and PRO. Ensures patient and stakeholder relevant endpoints and evidence generation strategies are implemented throughout the product lifecycle.Builds collaborative relationships with cross-functional leaders across Medical, Research & Development, Commercial, Market Access organizations to maximize evidence generation efforts to optimize launch and sustained reimbursement throughout the product lifecyclePartners with the Therapeutic Area (TA) heads and Regional/Country teams to develop TA business strategies and clinical development plans that will provide a competitive advantage to differentiated patient relevant evidence; drives efficient and innovative HEOR study development and study execution and dissemination.Continually monitors the global marketplace for market access issues, identifies access/demand hurdles, and creates plans to demonstrate the value and differentiation of assets within the therapeutic area portfolioEnsures Alexion maintains external credibility and relationships to validate research findings and communications